189 related articles for article (PubMed ID: 15750632)
1. YB-1 facilitates basal and 5-fluorouracil-inducible expression of the human major vault protein (MVP) gene.
Stein U; Bergmann S; Scheffer GL; Scheper RJ; Royer HD; Schlag PM; Walther W
Oncogene; 2005 May; 24(22):3606-18. PubMed ID: 15750632
[TBL] [Abstract][Full Text] [Related]
2. Cloning and initial analysis of the human multidrug resistance-related MVP/LRP gene promoter.
Lange C; Walther W; Schwabe H; Stein U
Biochem Biophys Res Commun; 2000 Nov; 278(1):125-33. PubMed ID: 11071864
[TBL] [Abstract][Full Text] [Related]
3. Different expression profiles of Y-box-binding protein-1 and multidrug resistance-associated proteins between alveolar and embryonal rhabdomyosarcoma.
Oda Y; Kohashi K; Yamamoto H; Tamiya S; Kohno K; Kuwano M; Iwamoto Y; Tajiri T; Taguchi T; Tsuneyoshi M
Cancer Sci; 2008 Apr; 99(4):726-32. PubMed ID: 18377424
[TBL] [Abstract][Full Text] [Related]
4. Efflux kinetics and intracellular distribution of daunorubicin are not affected by major vault protein/lung resistance-related protein (vault) expression.
van Zon A; Mossink MH; Schoester M; Scheper RJ; Sonneveld P; Wiemer EA
Cancer Res; 2004 Jul; 64(14):4887-92. PubMed ID: 15256459
[TBL] [Abstract][Full Text] [Related]
5. p53 Suppresses lung resistance-related protein expression through Y-box binding protein 1 in the MCF-7 breast tumor cell line.
Tian B; Liu J; Liu B; Dong Y; Liu J; Song Y; Sun Z
J Cell Physiol; 2011 Dec; 226(12):3433-41. PubMed ID: 21344396
[TBL] [Abstract][Full Text] [Related]
6. Disruption of the murine major vault protein (MVP/LRP) gene does not induce hypersensitivity to cytostatics.
Mossink MH; van Zon A; Fränzel-Luiten E; Schoester M; Kickhoefer VA; Scheffer GL; Scheper RJ; Sonneveld P; Wiemer EA
Cancer Res; 2002 Dec; 62(24):7298-304. PubMed ID: 12499273
[TBL] [Abstract][Full Text] [Related]
7. Prognostic implications of the nuclear localization of Y-box-binding protein-1 and CXCR4 expression in ovarian cancer: their correlation with activated Akt, LRP/MVP and P-glycoprotein expression.
Oda Y; Ohishi Y; Basaki Y; Kobayashi H; Hirakawa T; Wake N; Ono M; Nishio K; Kuwano M; Tsuneyoshi M
Cancer Sci; 2007 Jul; 98(7):1020-6. PubMed ID: 17459055
[TBL] [Abstract][Full Text] [Related]
8. Role of the human Y box-binding protein YB-1 in cellular sensitivity to the DNA-damaging agents cisplatin, mitomycin C, and ultraviolet light.
Ohga T; Koike K; Ono M; Makino Y; Itagaki Y; Tanimoto M; Kuwano M; Kohno K
Cancer Res; 1996 Sep; 56(18):4224-8. PubMed ID: 8797596
[TBL] [Abstract][Full Text] [Related]
9. The major vault protein is responsive to and interferes with interferon-gamma-mediated STAT1 signals.
Steiner E; Holzmann K; Pirker C; Elbling L; Micksche M; Sutterlüty H; Berger W
J Cell Sci; 2006 Feb; 119(Pt 3):459-69. PubMed ID: 16418217
[TBL] [Abstract][Full Text] [Related]
10. New invMED1 element cis-activates human multidrug-related MDR1 and MVP genes, involving the LRP130 protein.
Labialle S; Dayan G; Gayet L; Rigal D; Gambrelle J; Baggetto LG
Nucleic Acids Res; 2004; 32(13):3864-76. PubMed ID: 15272088
[TBL] [Abstract][Full Text] [Related]
11. Role of retinoblastoma protein and E2F-1 transcription factor in the acquisition of 5-fluorouracil resistance by colon cancer cells.
Obama K; Kanai M; Kawai Y; Fukushima M; Takabayashi A
Int J Oncol; 2002 Aug; 21(2):309-14. PubMed ID: 12118326
[TBL] [Abstract][Full Text] [Related]
12. Age associated high level of major vault protein is p53 dependent.
An HJ; Ryu SJ; Kim SY; Choi HR; Chung JH; Park SC
Cell Biochem Funct; 2009 Jul; 27(5):289-95. PubMed ID: 19472297
[TBL] [Abstract][Full Text] [Related]
13. The Mr 193,000 vault protein is up-regulated in multidrug-resistant cancer cell lines.
Schroeijers AB; Siva AC; Scheffer GL; de Jong MC; Bolick SC; Dukers DF; Slootstra JW; Meloen RH; Wiemer E; Kickhoefer VA; Rome LH; Scheper RJ
Cancer Res; 2000 Feb; 60(4):1104-10. PubMed ID: 10706131
[TBL] [Abstract][Full Text] [Related]
14. Expression and cellular distribution of major vault protein: a putative marker for pharmacoresistance in a rat model for temporal lobe epilepsy.
van Vliet EA; Aronica E; Redeker S; Gorter JA
Epilepsia; 2004 Dec; 45(12):1506-16. PubMed ID: 15571508
[TBL] [Abstract][Full Text] [Related]
15. Increased nuclear localization of transcription factor Y-box binding protein 1 accompanied by up-regulation of P-glycoprotein in breast cancer pretreated with paclitaxel.
Fujita T; Ito K; Izumi H; Kimura M; Sano M; Nakagomi H; Maeno K; Hama Y; Shingu K; Tsuchiya S; Kohno K; Fujimori M
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8837-44. PubMed ID: 16361573
[TBL] [Abstract][Full Text] [Related]
16. Major vault protein does not play a role in chemoresistance or drug localization in a non-small cell lung cancer cell line.
Huffman KE; Corey DR
Biochemistry; 2005 Feb; 44(7):2253-61. PubMed ID: 15709737
[TBL] [Abstract][Full Text] [Related]
17. Involvement of Nrf2 activation in resistance to 5-fluorouracil in human colon cancer HT-29 cells.
Akhdar H; Loyer P; Rauch C; Corlu A; Guillouzo A; Morel F
Eur J Cancer; 2009 Aug; 45(12):2219-27. PubMed ID: 19524433
[TBL] [Abstract][Full Text] [Related]
18. [Hypoxia-inducible factor-1 alpha dependent expression and significance of the related multidrug resistance genes induced by hypoxia in human hepatocarcinoma cell].
Zhu H; Chen XP; Luo SF; Guan J; Zhang WG; Zhang BX; Wang HP
Zhonghua Wai Ke Za Zhi; 2005 Mar; 43(5):277-81. PubMed ID: 15842930
[TBL] [Abstract][Full Text] [Related]
19. Tumor expression of major vault protein is an adverse prognostic factor for radiotherapy outcome in oropharyngeal carcinoma.
Silva P; West CM; Slevin N; Valentine H; Ryder WD; Hampson L; Bibi R; Sloan P; Thakker N; Homer J; Hampson I
Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):133-40. PubMed ID: 17459603
[TBL] [Abstract][Full Text] [Related]
20. TFPI-2 downregulates multidrug resistance protein in 5-FU-resistant human hepatocellular carcinoma BEL-7402/5-FU cells.
Lu F; Hou YQ; Song Y; Yuan ZJ
Anat Rec (Hoboken); 2013 Jan; 296(1):56-63. PubMed ID: 23125179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
